Literature DB >> 31082310

The Impact of Defective Viruses on Infection and Immunity.

Emmanuelle Genoyer1, Carolina B López1.   

Abstract

Defective viral genomes (DVGs) are generated during viral replication and are unable to carry out a full replication cycle unless coinfected with a full-length virus. DVGs are produced by many viruses, and their presence correlates with alterations in infection outcomes. Historically, DVGs were studied for their ability to interfere with standard virus replication as well as for their association with viral persistence. More recently, a critical role for DVGs in inducing the innate immune response during infection was appreciated. Here we review the role of DVGs of RNA viruses in shaping outcomes of experimental as well as natural infections and explore the mechanisms by which DVGs impact infection outcome.

Entities:  

Keywords:  antiviral immunity; defective interfering particles; defective viral genomes; defective virus; viral interference

Mesh:

Year:  2019        PMID: 31082310     DOI: 10.1146/annurev-virology-092818-015652

Source DB:  PubMed          Journal:  Annu Rev Virol        ISSN: 2327-056X            Impact factor:   10.431


  19 in total

1.  DVGfinder: A Metasearch Tool for Identifying Defective Viral Genomes in RNA-Seq Data.

Authors:  Maria J Olmo-Uceda; Juan C Muñoz-Sánchez; Wilberth Lasso-Giraldo; Vicente Arnau; Wladimiro Díaz-Villanueva; Santiago F Elena
Journal:  Viruses       Date:  2022-05-23       Impact factor: 5.818

Review 2.  Defective Interfering Particles of Negative-Strand RNA Viruses.

Authors:  Christopher M Ziegler; Jason W Botten
Journal:  Trends Microbiol       Date:  2020-03-26       Impact factor: 17.079

3.  Cell-to-Cell Variation in Defective Virus Expression and Effects on Host Responses during Influenza Virus Infection.

Authors:  Chang Wang; Christian V Forst; Tsui-Wen Chou; Adam Geber; Minghui Wang; Wissam Hamou; Melissa Smith; Robert Sebra; Bin Zhang; Bin Zhou; Elodie Ghedin
Journal:  mBio       Date:  2020-01-14       Impact factor: 7.867

4.  Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2.

Authors:  Jason Nomburg; Matthew Meyerson; James A DeCaprio
Journal:  Genome Med       Date:  2020-12-01       Impact factor: 11.117

5.  Cooperative nature of viral replication.

Authors:  Iván Andreu-Moreno; Juan-Vicente Bou; Rafael Sanjuán
Journal:  Sci Adv       Date:  2020-12-04       Impact factor: 14.136

6.  Innate Intracellular Antiviral Responses Restrict the Amplification of Defective Virus Genomes of Parainfluenza Virus 5.

Authors:  Elizabeth B Wignall-Fleming; Andri Vasou; Dan Young; John A L Short; David J Hughes; Steve Goodbourn; Richard E Randall
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 7.  Influenza virus DI particles: Defective interfering or delightfully interesting?

Authors:  Fadi G Alnaji; Christopher B Brooke
Journal:  PLoS Pathog       Date:  2020-05-21       Impact factor: 7.464

8.  Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication In Vivo and Reduced Immunogenicity.

Authors:  Cyril Le Nouën; Cindy L Luongo; Lijuan Yang; Steffen Mueller; Eckard Wimmer; Joshua M DiNapoli; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

9.  RNA-seq accuracy and reproducibility for the mapping and quantification of influenza defective viral genomes.

Authors:  Jeremy Boussier; Sandie Munier; Emna Achouri; Bjoern Meyer; Bernadette Crescenzo-Chaigne; Sylvie Behillil; Vincent Enouf; Marco Vignuzzi; Sylvie van der Werf; Nadia Naffakh
Journal:  RNA       Date:  2020-09-14       Impact factor: 4.942

10.  The Viral Polymerase Complex Mediates the Interaction of Viral Ribonucleoprotein Complexes with Recycling Endosomes during Sendai Virus Assembly.

Authors:  Emmanuelle Genoyer; Katarzyna Kulej; Chuan Tien Hung; Patricia A Thibault; Kristopher Azarm; Toru Takimoto; Benjamin A Garcia; Benhur Lee; Seema Lakdawala; Matthew D Weitzman; Carolina B López
Journal:  mBio       Date:  2020-08-25       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.